BOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) has launched PECAA promise, a portfolio of private label 1-day contact lenses that includes PECAA promise 1 day and PECAA promise 1 day premium, both available to PECAA Max members beginning June 1, 2026. The lenses were initially announced earlier this week on the first day of PECAA’s annual meeting. The launch aligns with PECAA’s commitment to protect and promote private practice, the company said in the announcement.
Quick Take
Professional Eye Care Associates of America (PECAA) has introduced 'PECAA promise,' a new private label contact lens portfolio featuring two daily disposable options: PECAA promise 1 day and PECAA promise 1 day premium. Available starting June 1, 2026, for PECAA Max members, the initiative is designed to bolster independent practice profitability and patient retention.
Why It Matters
Private label contact lenses are a strategic tool for independent ECPs to combat 'showrooming' and price-shopping at big-box or online retailers. By offering a high-quality daily disposable that patients cannot easily price-match elsewhere, practices can secure long-term loyalty and protect their margins in the highly competitive contact lens market. This move reflects a broader industry trend where buying groups provide exclusive products to help private practices differentiate their value proposition and maintain control over the patient journey.
Key Details
Practice Implications
Practice owners can use these private label lenses to create a unique offering that is exclusive to their office, reducing the likelihood of patients requesting prescriptions for online fulfillment. The two-tier system—standard and premium—allows for clinical flexibility in meeting different patient needs and price points while maintaining practice-controlled distribution.
Who's Affected
What's Next
The lenses are scheduled to become available to PECAA Max members on June 1, 2026. Practice owners should evaluate their current daily disposable offerings and consider how a private label option fits into their patient retention and profitability strategies ahead of the rollout.
AI-generated summary — always read the original source for full context
No comments yet. Be the first to share your thoughts.
